Amgen Inc vs. Outlook Therapeutics, Inc. Common Stock
Amgen Inc and Outlook Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AMGN | OTLK | |
|---|---|---|
| Market Cap | $251.94 billion | $114.23 million |
AMGN leads on 1 of 1 size & scale factors.
Dividend
| AMGN | OTLK | |
|---|---|---|
| Dividend Yield | 2.18% | — |
AMGN and OTLK split the dividend factors evenly.
Risk & Sentiment
| AMGN | OTLK | |
|---|---|---|
| Short Interest | 1.66% | 0.03% |
OTLK leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, OTLK overview, OTLK financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.